Literature DB >> 10772683

Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors.

J Savla1, T T Chen, N R Schneider, C F Timmons, O Delattre, G E Tomlinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10772683     DOI： 10.1093/jnci/92.8.648

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  17 in total

1.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.

Authors:  C W Roberts; S A Galusha; M E McMenamin; C D Fletcher; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

3.  Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.

Authors:  George Toth; Claudia B Zraly; Tricia L Thomson; Carolyn Jones; Shawn Lapetino; Jonathan Muraskas; Jiwang Zhang; Andrew K Dingwall
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

4.  Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.

Authors:  Emilia M Pinto; Dima Hamideh; Armita Bahrami; Brent A Orr; Tong Lin; Stanley Pounds; Gerard P Zambetti; Alberto S Pappo; Amar Gajjar; Sameer Agnihotri; Alberto Broniscer
Journal:  Acta Neuropathol       Date:  2018-02-10       Impact factor: 17.088

Review 5.  Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Authors:  Sarah G Mitchell; Bojana Pencheva; Christopher C Porter
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

Review 6.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

7.  Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.

Authors:  Hironori Fujisawa; Koichi Misaki; Yasushi Takabatake; Mitsuhiro Hasegawa; Junkoh Yamashita
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

8.  Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.

Authors:  Hironori Fujisawa; Yasushi Takabatake; Toshio Fukusato; Osamu Tachibana; Yoshitake Tsuchiya; Junkoh Yamashita
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.130

9.  Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation.

Authors:  Costanza Bacci; Roberta Sestini; Aldesia Provenzano; Irene Paganini; Irene Mancini; Berardino Porfirio; Rossella Vivarelli; Maurizio Genuardi; Laura Papi
Journal:  Neurogenetics       Date:  2009-07-07       Impact factor: 2.660

10.  Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Authors:  Elizabeth M Algar; Andrea Muscat; Vinod Dagar; Christian Rickert; C W Chow; Jaclyn A Biegel; Paul G Ekert; Richard Saffery; Jeff Craig; Ricky W Johnstone; David M Ashley
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.